TrialInvestigational new drugs2022

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.

Steven F Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.